Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Ajanta Pharma Ltd

NSE: AJANTPHARM · BSE: 532331 · Pharmaceuticals & Biotechnology · 33 announcements

Share price
₹3,573.90
Market cap
₹44,659 Cr
Revenue (annual)
₹5,453 Cr
Net profit (annual)
₹1,056 Cr
P/E (TTM)
39.4×Sector 47.4×
Promoter holding
63.48%-2.77% QoQ
FII holding
7.68%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

15:24 IST BSE
Financial Results

Ajanta Pharma Financial Results

Ajanta Pharma Ltd reported its FY 2026 financial results, with annual consolidated revenue crossing ₹5,453 Crore and PAT exceeding ₹1,056 Crore. The company achieved 21% quarterly revenue growth and 18% PAT growth. Branded generics across India, Asia, and Africa remains the core business, contributing 68% of total revenue.